Clinical trial · Interventional
The Effect of Berries on Lung Cancer Tumors
Berry Interventional Trial (BIT) in Resected Non-Small Cell Lung Cancer
NCT00681512CI-TRIAL-00031558terminatedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): slow accrual
Summary
Brief summary (as posted)
The purpose of this study is to determine how berries affect cancer tumors in patients with non-small cell lung cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Non Small Cell Lung Cancer | Lung Non-Small Cell Carcinoma | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| berry powder | Dietary Supplement | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Assessment of blueberry and black raspberry phenolics in plasma and urine
- timeFrame
- upon completion of 4 to 5 weeks of daily consumption of berry powder
- description
- In addition to determining the berry phytochemical profile in plasma and urine, this study will attempt to establish the effect of berries on modulating immunological profiles such as the complete blood count, and T, B and natural killer (NK) cell populations and circulating biomarkers (serum proteins and microRNAs). This pilot study will establish the safety and feasibility of conducting a larger clinical trial with berry intervention.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria (lung cancer survivors): * men treated for lung cancer, women treated for lung cancer and with no child-bearing potential (hysterectomy, tubal ligation, post-menopausal women) Exclusion Criteria (lung cancer survivors): * women who are on hormone replacement therapy * women who are pregnant, or planning for pregnancy * history of lung transplant * prison inmate * inability to take oral medication or food * known or suspected allergy to berries or berry products * HIV patients Inclusion Criteria (volunteers): * adult men, adult women with no child bearing potential (hysterectomy, tubal ligation, post-menopausal women) Exclusion Criteria (volunteers): * women who are on hormone replacement therapy * women who are pregnant, or planning for pregnancy * history of lung transplant * prison inmate * inability to take oral medication or food * known or suspected allergy to berries or berry products * HIV patients
References
Publications (0)
Data not yet available
No reference posted for this study.